ZNF711
protein-codingzinc finger protein 711, the group of Zinc fingers C2H2-type
Gene summary
This gene encodes a zinc finger protein of unknown function. It bears similarity to a zinc finger protein which acts as a transcriptional activator. This gene lies in a region of the X chromosome which has been associated with cognitive disability. [provided by RefSeq, Jul 2008]
- ZNF6
- MRX65
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~29.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0019181
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010430
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0100148
Submitter: ClinGen
*ZNF711* was first reported in relation to X-linked complex neurodevelopmental disorder (NDD) in 2009 by Tarpey et al. (PMID: 19377476) who reported a frameshift and nonsense variant transmitted within two large pedigrees with several affected males with intellectual disability and no other observable phenotypes. van der Werf et al. (2017, PMID: 27993705) reported two multigenerational families with X-linked complex NDD segregating with *ZNF711* variants (frameshift and missense). Four additional *ZNF711* variants were reported by Wang et al. (2022, PMID: 34992252); 3 nonsense variants and one *de novo* missense variant observed in families or individual probands affected by X-linked complex NDD. Segregation evidence from Tarpey et al. (2009), van der Werf et al. (2017), and Wang et al. (2022) resulted in 3 additional points. The maximum score for genetic evidence (12 points) was reached. Of note, missense variants in individual probands were of unclear pathogenicity and were not scored (PMIDs: 25649377, 28135719). An additional novel variant (c.127_129delGTT, p.V43del, GRCh37/hg19; ClinVar SCV:002030756.1) has been identified in a family affected by X-linked complex NDD enrolled in the Brain Gene Registry, but was not scored at this time. Experimental evidence implicates *ZNF711* in a regulatory network of syntenic, X-linked neurodevelopmental disorder-associated genes (*KDM5C, ARX, PHF8*) based on a series of studies demonstrating spatiotemporal expression patterns in developing human and mouse brains (PMID: 34356104), protein interactions (PMID: 31691806, PMID: 20346720), functional alteration in patient-derived cells (PMID: 34356104), and rescue experiments in cell culture models (PMID: 34356104 , PMID: 31691806) that are consistent with observed clinical phenotypes. In summary, there is definitive evidence supporting the relationship between *ZNF711* and X-linked complex neurodevelopmental disorder. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on November 3, 2020. It was reevaluated on September 22, 2022 (SOP Version 9). As a result of this reevaluation, the classification increased from Moderate to Definitive with the addition of new cases and experimental evidence.
Inheritance Pattern: XL
Disease ID:MONDO:0010430
Submitter: Ambry Genetics
Inheritance Pattern: XL
Disease ID:MONDO:0010430
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010430
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZNF711 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001330574.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 19 | 15 | 2 | 36 | ||
| missense | 1 | 169 | 14 | 1 | 185 | |
| nonsense | 2 | 3 | 4 | 9 | ||
| start loss | 0 | |||||
| frameshift | 5 | 6 | 2 | 13 | ||
| splice donor/acceptor (+/-2bp) | 9 | 9 | ||||
| Total | 7 | 10 | 203 | 29 | 3 | 252 |
Highest pathogenic variant AF is 9.1150474e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001317503.1 | 8 | MANE Select | |
| Ensembl | ENSP00000502839.1 | 8 | MANE Select | |
| RefSeq | NP_001362360.1 | 8 | Standard | |
| RefSeq | NP_001362361.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gene expression (Transcription)
- Generic Transcription Pathway
- RNA Polymerase II Transcription
Biological Process
- regulation of transcription by RNA polymerase II
- positive regulation of transcription, DNA-templated
Molecular Function
- RNA polymerase II regulatory region sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- protein binding
- chromatin DNA binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000373165
- Coding exons
- 7
- Length
- 29372
- Individuals with no LoFs
- 125346
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 0
- Defined
- 125347
- p
- 0.00000399
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.40 | 165 | 278 | 0.594 | 0.0000194 | 5089 |
| Missense (PolyPhen) | 46 | 129.92 | 0.35406 | 2496 | ||
| Synonymous | 0.247 | 95 | 98.1 | 0.968 | 0.00000722 | 1361 |
| Loss of Function | 3.80 | 2 | 20.6 | 0.0970 | 0.00000174 | 386 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000012 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription regulator required for brain development. Probably acts as a transcription factor that binds to the promoter of target genes and recruits PHF8 histone demethylase, leading to activate expression of genes involved in neuron development, such as KDM5C. {ECO:0000269|PubMed:20346720}.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- RVIS EVS
- -0.23
- RVIS percentile EVS
- 37.11
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.698
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |